H4381

Sigma-Aldrich

6-Hydroxydopamine hydrochloride

≥97% (titration), powder

Synonym(s):
2-(2,4,5-Trihydroxyphenyl)ethylamine hydrochloride, 6-OHDA, 2,4,5-Trihydroxyphenethylamine hydrochloride, 2,5-Dihydroxytyramine hydrochloride
Linear Formula:
(HO)3C6H2CH2CH2NH2 · HCl
CAS Number:
Molecular Weight:
205.64
Beilstein/REAXYS Number:
4274007
EC Number:
MDL number:
PubChem Substance ID:
NACRES:
NA.77

Quality Level

assay

≥97% (titration)

form

powder

color

off-white to brown

mp

232-233 °C (dec.) (lit.)

solubility

H2O: >50 mg/mL, clear, yellow to brown

storage temp.

room temp

SMILES string

Cl.NCCc1cc(O)c(O)cc1O

InChI

1S/C8H11NO3.ClH/c9-2-1-5-3-7(11)8(12)4-6(5)10;/h3-4,10-12H,1-2,9H2;1H

InChI key

QLMRJHFAGVFUAC-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

6-Hydroxydopamine hydrochloride (6-OHDA) is a neurotoxin, commonly used to induce Parkinson′s disease (PD). 6-OHDA causes death of dopaminergic neurons in substantia nigra pars compacta progressively mimicking PD. 6-OHDA is highly oxidizable and cannot cross blood brain barrier. 6-OHDA exerts cytotoxicity by generating reactive oxygen species, initiating cellular stress and cell death. 6-OHDA leads to neuronal cell death in many in vitro models like primary neuronal culture, human neuroblastoma cell line and rat adrenal pheochromocytoma cell line, PC12.

Application

6-hydroxydopamine hydrochloride has been used:
  • to induce Parkinson′s disease (PD) in rats
  • to analyse cytotoxic effect of 6-OHDA on PC12 cell line
  • to induce noradrenergic (NA) neuron deletion from the locus-coeruleus

Packaging

1 g in glass bottle
100, 500 mg in glass insert

Biochem/physiol Actions

Neurotoxin that destroys catecholaminergic terminals.

Caution

Hygroscopic

Reconstitution

Dissolve in oxygen-free water containing 0.1% sodium metabisulfite or other antioxidants.
Solutions should be freshly prepared and protected from exposure to light. Solutions turn red as it oxidizes.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Precautionary Statements

Target Organs

Respiratory system

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

RIDADR

NONH for all modes of transport

WGK Germany

WGK 3

Certificate of Analysis

Certificate of Origin

The 6-hydroxydopamine model and parkinsonian pathophysiology: Novel findings in an older model
Hernandez-Baltazar D, et al.
Neurologia (Barcelona, Spain), 32(8), 533-539 (2017)
Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and-independent action
Saito Y, et al.
Free Radical Biology & Medicine, 42(5), 675-685 (2007)
Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease
Han F, et al.
Cytotherapy, 17(5), 665-679 (2015)
Kryspin Andrzejewski et al.
Journal of biomedical science, 24(1), 24-24 (2017-03-30)
Malfunctioning of the serotonergic system in Parkinson's disease may contribute to non-motor symptoms such as respiratory complications. Thus the aim of our study was to investigate the role of serotonin 5-HT Wistar rats were lesioned unilaterally with double 6-hydroxydopamine (6-OHDA)...
Hanming Ge et al.
Experimental and molecular pathology, 109, 16-24 (2019-05-09)
Parkinson's disease (PD) is a chronic neurodegenerative disease characterized by loss of dopaminergic neurons in the substantia nigra. Recently, microRNAs (miRNAs) were emerging as important mediators in dopaminergic neuron biology. This study determined miR-410 expression in the 6-hydroxydopamine (6-OHDA)-induced in...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.